- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 255/00 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups
Patent holdings for IPC class C07D 255/00
Total number of patents in this class: 15
10-year publication summary
|
0
|
0
|
1
|
0
|
3
|
1
|
0
|
0
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America as represented by the Secretary of the Navy | 2862 |
5 |
| Boehringer Ingelheim International GmbH | 4485 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Massachusetts Institute of Technology | 10324 |
1 |
| Children's Medical Center Corporation | 1981 |
1 |
| GE Healthcare AS | 201 |
1 |
| Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 56 |
1 |
| Humanwell Healthcare (Group) Co., Ltd. | 40 |
1 |
| Beijing Innocare Pharma Tech Co., Ltd. | 98 |
1 |
| Biohaven Therapeutics Ltd. | 124 |
1 |
| Other owners | 0 |